Albemarle (ALB) Financials

$170.82 +0.61 (+0.36%)

As of 01:52 PM Eastern

Annual Income Statements for Albemarle

This table shows Albemarle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	335	644	55	694	533	376	124	2,690	1,573	-1,316	-677
Consolidated Net Income / (Loss)	360	681	99	739	604	447	200	2,815	1,671	-1,135	-465
Net Income / (Loss) Continuing Operations	328	479	99	739	604	447	200	2,815	1,671	-1,135	-465
Total Pre-Tax Income	311	515	447	795	563	374	134	2,433	247	-1,764	-552
Total Operating Income	345	479	572	701	666	506	798	2,470	252	-1,777	-367
Total Gross Profit	860	970	1,106	1,217	1,258	995	998	3,075	1,186	63	669
Total Revenue	2,826	2,677	3,072	3,375	3,589	3,129	3,328	7,320	9,617	5,378	5,143
Operating Revenue	2,826	2,677	3,072	3,375	3,589	3,129	3,328	7,320	9,617	5,378	5,143
Total Cost of Revenue	1,966	1,707	1,966	2,158	2,332	2,134	2,330	4,246	8,431	5,315	4,474
Operating Cost of Revenue	1,966	1,707	1,966	2,158	2,332	2,134	2,330	4,246	8,431	5,315	4,474
Total Operating Expenses	515	492	535	516	592	489	200	596	1,005	1,839	1,036
Selling, General & Admin Expense	300	354	450	446	533	430	441	524	910	618	550
Research & Development Expense	89	80	84	70	58	59	54	72	86	87	51
Impairment Charge	-	-	-	-	-	-	-	-	0.00	0.00	427
Restructuring Charge	125	57	-	-	-	-	-	0.00	9.49	1,134	7.70
Total Other Income / (Expense), net	-34	37	-125	94	-103	-132	-665	-45	66	13	-185
Interest Expense	82	65	115	52	58	73	61	123	116	166	208
Other Income / (Expense), net	47	102	-9.51	146	-45	-59	-603	78	182	178	23
Income Tax Expense	11	96	432	145	88	54	29	391	430	87	157
Other Gains / (Losses), net	28	60	84	89	130	128	96	772	1,854	715	244
Preferred Stock Dividends Declared	-	-	-	-	-	-	-	0.00	0.00	137	167
Net Income / (Loss) Attributable to Noncontrolling Interest	25	37	45	46	71	71	76	125	97	44	45
Basic Earnings per Share	$3.01	$5.73	$0.49	$6.40	$5.03	$3.53	$1.07	$22.97	$13.41	($11.20)	($5.76)
Weighted Average Basic Shares Outstanding	111.18M	112.38M	110.91M	108.43M	105.95M	106.40M	115.84M	117.12M	117.32M	117.52M	117.66M
Diluted Earnings per Share	$3.00	$5.68	$0.49	$6.34	$5.02	$3.52	$1.06	$22.84	$13.36	($11.20)	($5.76)
Weighted Average Diluted Shares Outstanding	111.56M	113.24M	112.38M	109.46M	106.32M	106.81M	116.54M	117.79M	117.77M	117.52M	117.66M
Weighted Average Basic & Diluted Shares Outstanding	112.25M	112.57M	111.90M	108.40M	106.21M	116.63M	117.20M	-	117.40M	117.57M	117.85M
Cash Dividends to Common per Share	$1.16	$1.22	$1.28	$1.34	$1.47	$1.54	$1.56	$1.58	$1.60	$1.61	$1.62

This table shows Albemarle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	303	-618	-9.14	-230	-1,111	34	-0.34	-19	-202	-456	277
Consolidated Net Income / (Loss)	321	-603	17	-177	-1,061	85	49	35	-148	-402	329
Net Income / (Loss) Continuing Operations	321	-603	17	-177	-1,061	85	49	35	-148	-402	329
Total Pre-Tax Income	-158	-921	-168	-494	-1,179	77	-19	-8.97	-239	-285	254
Total Operating Income	-140	-850	-180	-493	-1,109	4.40	20	48	-217	-217	234
Total Gross Profit	55	-704	39	-11	-104	138	156	197	118	198	501
Total Revenue	2,311	2,356	1,361	1,430	1,355	1,232	1,077	1,330	1,308	1,428	1,429
Operating Revenue	2,311	2,356	1,361	1,430	1,355	1,232	1,077	1,330	1,308	1,428	1,429
Total Cost of Revenue	2,256	3,060	1,322	1,441	1,459	1,094	921	1,133	1,190	1,230	928
Operating Cost of Revenue	2,256	3,060	1,322	1,441	1,459	1,094	921	1,133	1,190	1,230	928
Total Operating Expenses	195	217	218	482	1,005	134	137	149	335	415	172
Selling, General & Admin Expense	172	187	161	166	154	100	124	132	139	156	137
Research & Development Expense	21	23	24	21	22	20	14	12	13	12	9.17
Restructuring Charge	1.76	-	34	295	828	-	-1.06	4.45	2.28	2.04	26
Total Other Income / (Expense), net	-18	0.11	12	-1.52	-70	72	-39	-56	-22	-68	-74
Interest Expense	29	34	38	35	48	45	49	50	51	58	33
Other Income / (Expense), net	11	34	50	34	-22	117	10	-6.56	29	-9.83	-41
Income Tax Expense	-8.55	119	-3.72	-31	111	11	-3.98	34	-31	157	22
Other Gains / (Losses), net	470	437	181	287	229	19	64	78	61	41	96
Preferred Stock Dividends Declared	0.00	-	12	42	42	42	42	42	42	42	42
Net Income / (Loss) Attributable to Noncontrolling Interest	18	14	14	12	8.35	9.82	7.95	12	13	12	9.89
Basic Earnings per Share	$2.58	($5.28)	($0.08)	($1.96)	($9.45)	$0.29	$0.00	($0.16)	($1.72)	($3.88)	$2.35
Weighted Average Basic Shares Outstanding	117.35M	117.32M	117.45M	117.53M	117.54M	117.52M	117.60M	117.67M	117.69M	117.66M	117.85M
Diluted Earnings per Share	$2.57	($5.24)	($0.08)	($1.96)	($9.45)	$0.29	$0.00	($0.16)	($1.72)	($3.88)	$2.34
Weighted Average Diluted Shares Outstanding	117.78M	117.77M	117.45M	117.53M	117.54M	117.52M	117.60M	117.67M	117.69M	117.66M	118.61M
Weighted Average Basic & Diluted Shares Outstanding	117.35M	117.40M	117.53M	117.53M	117.54M	117.57M	117.66M	117.68M	117.70M	117.85M	117.93M
Cash Dividends to Common per Share	$0.40	-	$0.40	$0.40	$0.41	-	$0.41	$0.41	$0.41	-	$0.41

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-2,276	2,056	-1,132	-544	58	134	-307	1,060	-609	345	426
Net Cash From Operating Activities	361	736	304	546	719	799	344	1,908	1,327	688	1,282
Net Cash From Continuing Operating Activities	361	736	304	546	719	799	344	1,908	1,327	688	1,282
Net Income / (Loss) Continuing Operations	360	681	99	739	604	447	200	2,815	1,671	-1,135	-465
Consolidated Net Income / (Loss)	360	681	99	739	604	447	200	2,815	1,671	-1,135	-465
Depreciation Expense	260	226	197	201	213	232	254	301	430	589	659
Non-Cash Adjustments To Reconcile Net Income	-81	-432	172	-291	1.48	209	-183	113	31	612	616
Changes in Operating Assets and Liabilities, net	-178	260	-165	-103	-100	-89	73	-1,321	-805	622	473
Net Cash From Investing Activities	-2,161	2,920	-358	-304	-1,664	-864	-667	-1,423	-2,565	-1,585	-146
Net Cash From Continuing Investing Activities	-2,161	2,920	-358	-304	-1,664	-864	-667	-1,423	-2,565	-1,585	-146
Purchase of Property, Plant & Equipment	-228	-197	-318	-700	-852	-850	-954	-1,262	-2,155	-1,681	-590
Purchase of Investments	1.00	0.00	-3.84	-5.87	-2.57	-2.43	-6.49	-0.71	-1.20	67	114
Sale of Property, Plant & Equipment	-	-	0.00	0.00	10	-	-	0.00	0.00	29	33
Sale and/or Maturity of Investments	98	0.31	-	-	0.38	0.90	3.77	1.94	17	0.00	297
Net Cash From Financing Activities	-478	-1,580	-1,087	-787	1,043	177	50	612	624	1,242	-834
Net Cash From Continuing Financing Activities	-478	-1,580	-1,087	-787	1,043	177	50	612	624	1,242	-834
Repayment of Debt	-2,580	-1,416	-825	-114	-314	-116	-1,140	-1,113	588	-116	-511
Payment of Dividends	-143	-171	-177	-159	-235	-194	-274	-229	-293	-348	-375
Issuance of Debt	2,250	0.00	166	0.00	1,598	452	0.00	1,964	356	-519	57
Issuance of Preferred Equity	-	-	-	-	-	-	-	0.00	0.00	2,237	0.00
Other Financing Activities, net	-1.03	7.21	-0.14	-14	-6.22	35	10	-11	-27	-12	-4.02
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	-	124

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	1.93	-712	1,166	-226	-166	-472	326	288	125	-314	-528
Net Cash From Operating Activities	629	-98	98	363	241	0.67	547	-7.20	356	388	346
Net Cash From Continuing Operating Activities	629	-98	98	363	241	0.67	547	-7.20	356	388	346
Net Income / (Loss) Continuing Operations	321	-603	17	-177	-1,061	85	49	35	-148	-402	329
Consolidated Net Income / (Loss)	321	-603	17	-177	-1,061	85	49	35	-148	-402	329
Depreciation Expense	105	144	124	138	164	163	162	169	164	164	158
Non-Cash Adjustments To Reconcile Net Income	417	261	-107	133	759	-665	364	-103	147	210	4.90
Changes in Operating Assets and Liabilities, net	-215	100	64	268	379	417	-28	-108	192	416	-145
Net Cash From Investing Activities	-663	-1,066	-495	-450	-302	-328	-129	363	-153	-177	541
Net Cash From Continuing Investing Activities	-663	-1,066	-495	-450	-302	-328	-129	363	-153	-177	541
Purchase of Property, Plant & Equipment	-546	-684	-579	-448	-303	-356	-183	-120	-132	-155	-99
Purchase of Investments	-0.09	0.08	-0.07	83	-83	-0.05	-0.06	171	-171	114	-0.06
Divestitures	-	-	-	-	-	-	0.00	-	-	-	525
Sale and/or Maturity of Investments	-82	1.50	85	-	-	-1.13	54	288	149	-143	115
Net Cash From Financing Activities	100	397	1,557	-113	-110	-93	-120	-91	-91	-533	-1,413
Net Cash From Continuing Financing Activities	100	397	1,557	-113	-110	-93	-120	-91	-91	-533	-1,413
Repayment of Debt	174	415	-651	-36	-30	-31	-11	-21	-20	-460	-1,310
Payment of Dividends	-73	-73	-47	-105	-108	-89	-107	-89	-89	-89	-127
Issuance of Debt	-	56	29	27	28	28	0.00	19	19	18	18
Other Financing Activities, net	-1.22	-1.23	-11	-0.06	-0.19	-0.74	-1.72	-0.04	0.08	-2.34	4.98
Effect of Exchange Rate Changes	-	55	5.16	-	5.83	-52	28	-	-	-	-2.05

This table presents Albemarle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	9,598	8,161	7,751	7,582	9,861	10,451	10,974	15,457	18,271	16,610	16,374
Total Current Assets	1,831	3,307	2,478	1,998	2,225	2,206	1,994	5,187	5,217	3,842	4,008
Cash & Equivalents	214	2,270	1,137	555	613	747	439	1,499	890	1,192	1,618
Accounts Receivable	473	528	572	658	680	593	623	1,377	1,722	981	699
Inventories, net	440	450	593	701	769	750	799	2,076	2,161	1,503	1,179
Other Current Assets	63	59	136	85	163	116	133	235	443	167	140
Other Current Nonoperating Assets	642	0.00	39	-	-	-	-	-	-	-	372
Plant, Property, & Equipment, net	2,321	2,360	2,493	3,021	4,909	5,355	5,910	6,963	9,495	9,331	8,612
Plant, Property & Equipment, gross	3,700	3,911	4,124	4,799	6,818	7,428	8,075	9,354	12,234	12,523	11,769
Accumulated Depreciation	1,379	1,550	1,631	1,778	1,908	2,073	2,165	2,391	2,739	3,192	3,156
Total Noncurrent Assets	5,446	2,494	2,780	2,562	2,726	2,890	3,071	3,307	3,559	3,436	3,754
Long-Term Investments	436	458	534	529	580	656	912	1,151	1,370	1,118	901
Goodwill	1,461	1,540	1,610	1,567	1,579	1,666	1,598	1,618	1,630	1,583	1,500
Intangible Assets	384	355	422	386	355	349	309	288	262	231	214
Other Noncurrent Operating Assets	194	142	74	80	213	219	252	251	297	505	647
Other Noncurrent Nonoperating Assets	2,971	0.00	140	-	-	-	-	-	-	0.00	492
Total Liabilities & Shareholders' Equity	9,598	8,161	7,751	7,582	9,861	10,451	10,974	15,457	18,271	16,610	16,374
Total Liabilities	6,197	4,219	3,933	3,823	5,767	5,982	5,169	7,266	8,606	6,410	6,593
Total Current Liabilities	1,617	1,140	1,201	1,183	1,409	1,802	1,874	2,741	3,560	1,966	1,798
Short-Term Debt	675	248	422	307	187	805	390	2.13	626	398	74
Accounts Payable	240	282	419	523	574	483	648	2,052	2,088	944	914
Accrued Expenses	313	322	268	257	576	441	763	506	545	468	522
Dividends Payable	32	34	35	35	39	41	45	46	47	61	61
Current Deferred & Payable Income Tax Liabilities	27	254	55	61	32	32	28	135	255	95	35
Other Current Nonoperating Liabilities	330	0.00	1.94	-	-	-	-	-	-	0.00	192
Total Noncurrent Liabilities	4,580	3,079	2,732	2,639	4,358	4,181	3,294	4,525	5,045	4,443	4,795
Long-Term Debt	3,142	2,122	1,415	1,398	2,863	2,767	2,004	3,215	3,541	3,118	3,119
Noncurrent Deferred & Payable Income Tax Liabilities	385	413	370	383	398	395	353	481	558	358	368
Noncurrent Employee Benefit Liabilities	350	349	347	332	343	389	273	192	177	148	162
Other Noncurrent Operating Liabilities	239	195	599	527	755	629	664	637	769	819	1,085
Other Noncurrent Nonoperating Liabilities	464	0.00	0.61	-	-	-	-	-	-	0.00	60
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,401	3,943	3,818	3,759	4,094	4,469	5,806	8,191	9,665	10,200	9,781
Total Preferred & Common Equity	3,254	3,795	3,675	3,585	3,932	4,268	5,625	7,983	9,412	9,962	9,533
Preferred Stock	-	-	-	-	-	-	-	-	0.00	2,235	2,235
Total Common Equity	3,254	3,795	3,675	3,585	3,932	4,268	5,625	7,983	9,412	7,726	7,298
Common Stock	2,060	2,086	1,865	1,370	1,385	1,439	2,921	2,942	2,954	2,987	3,019
Retained Earnings	1,615	2,122	2,035	2,566	2,943	3,155	3,097	5,601	6,987	5,482	4,614
Accumulated Other Comprehensive Income / (Loss)	-421	-412	-226	-351	-396	-326	-392	-561	-529	-742	-335
Noncontrolling Interest	147	148	143	174	161	200	180	208	253	238	248

This table presents Albemarle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	19,110	18,883	18,271	19,032	18,388	17,455	16,610	16,999	17,292	17,148	15,140
Total Current Assets	7,455	7,126	5,217	5,823	5,226	4,670	3,842	4,107	4,505	4,555	3,259
Cash & Equivalents	1,600	1,602	890	2,056	1,830	1,665	1,192	1,519	1,807	1,932	1,090
Accounts Receivable	1,771	1,708	1,722	1,313	1,198	1,018	981	808	880	841	659
Inventories, net	3,659	3,404	2,161	1,905	1,800	1,658	1,503	1,656	1,641	1,533	1,347
Other Current Assets	425	412	443	550	398	329	167	125	178	249	163
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	7,855	8,309	9,495	9,756	9,837	9,258	9,331	9,303	9,253	9,222	8,525
Plant, Property & Equipment, gross	10,397	10,929	12,234	12,588	12,789	12,376	12,523	12,660	12,793	12,903	11,823
Accumulated Depreciation	2,542	2,621	2,739	2,832	2,952	3,118	3,192	3,357	3,540	3,681	3,298
Total Noncurrent Assets	3,800	3,449	3,559	3,454	3,326	3,527	3,436	3,589	3,534	3,371	3,355
Long-Term Investments	1,621	1,254	1,370	1,259	1,161	1,180	1,118	1,125	890	914	1,023
Goodwill	1,635	1,606	1,630	1,614	1,601	1,638	1,583	1,606	1,671	1,491	1,488
Intangible Assets	274	261	262	252	243	246	231	230	235	230	208
Other Noncurrent Operating Assets	270	329	297	329	321	464	505	628	738	736	637
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	0.00
Total Liabilities & Shareholders' Equity	19,110	18,883	18,271	19,032	18,388	17,455	16,610	16,999	17,292	17,148	15,140
Total Liabilities	9,022	8,721	8,606	7,233	6,905	6,965	6,410	6,725	6,793	6,879	5,031
Total Current Liabilities	4,292	3,942	3,560	2,051	1,958	1,911	1,966	1,944	1,950	2,004	1,576
Short-Term Debt	6.25	162	626	5.08	3.21	3.01	398	410	445	445	75
Accounts Payable	3,052	2,607	2,088	1,296	1,323	1,223	944	918	859	903	934
Accrued Expenses	673	689	545	455	508	513	468	380	415	501	453
Dividends Payable	47	47	47	58	61	61	61	61	61	61	61
Current Deferred & Payable Income Tax Liabilities	513	436	255	237	63	111	95	175	170	93	53
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	0.00
Total Noncurrent Liabilities	4,730	4,779	5,045	5,182	4,947	5,054	4,443	4,781	4,843	4,875	3,456
Long-Term Debt	3,509	3,496	3,541	3,519	3,520	3,566	3,118	3,129	3,178	3,181	1,807
Noncurrent Deferred & Payable Income Tax Liabilities	328	290	558	657	501	526	358	378	367	407	369
Noncurrent Employee Benefit Liabilities	192	187	177	171	168	170	148	148	154	150	161
Other Noncurrent Operating Liabilities	701	807	769	834	758	792	819	1,126	1,145	1,137	1,119
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	10,088	10,162	9,665	11,800	11,483	10,491	10,200	10,274	10,499	10,269	10,108
Total Preferred & Common Equity	9,815	9,898	9,412	11,533	11,223	10,241	9,962	10,028	10,241	9,996	9,850
Preferred Stock	-	-	0.00	2,235	2,235	2,235	2,235	2,235	2,235	2,235	2,235
Total Common Equity	9,815	9,898	9,412	9,297	8,987	8,005	7,726	7,793	8,005	7,761	7,615
Common Stock	2,937	2,947	2,954	2,964	2,971	2,980	2,987	2,993	3,003	3,012	3,031
Retained Earnings	7,396	7,652	6,987	6,931	6,654	5,496	5,482	5,434	5,367	5,117	4,843
Accumulated Other Comprehensive Income / (Loss)	-518	-701	-529	-597	-638	-470	-742	-633	-365	-369	-259
Noncontrolling Interest	273	265	253	267	261	250	238	246	258	273	258

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.57%	-5.28%	14.75%	9.86%	6.36%	-12.83%	6.36%	119.96%	31.38%	-44.08%	-4.37%
EBITDA Growth	82.20%	23.62%	-5.89%	38.04%	-20.39%	-18.64%	-33.82%	534.36%	-69.67%	-216.86%	131.13%
EBIT Growth	54.16%	47.92%	-3.15%	50.69%	-26.73%	-28.04%	-56.32%	1,206.05%	-82.97%	-468.25%	78.45%
NOPAT Growth	34.29%	16.98%	-95.08%	2,891.20%	-2.01%	-23.09%	44.06%	233.12%	-109.04%	-563.72%	79.34%
Net Income Growth	123.77%	89.07%	-85.39%	643.09%	-18.24%	-26.10%	-55.23%	1,307.97%	-40.66%	-167.97%	59.03%
EPS Growth	77.51%	89.33%	-91.37%	1,193.88%	-20.82%	-29.88%	-69.89%	2,054.72%	-41.51%	-183.83%	48.57%
Operating Cash Flow Growth	-26.76%	103.85%	-58.67%	79.67%	31.71%	11.06%	-56.91%	454.19%	-30.53%	-47.03%	86.41%
Free Cash Flow Firm Growth	-364.37%	132.71%	-137.04%	100.17%	-289,677.35%	74.63%	-485.31%	237.94%	-244.76%	63.62%	185.41%
Invested Capital Growth	114.83%	-4.32%	6.18%	14.91%	35.65%	11.50%	31.83%	0.00%	31.97%	-1.30%	-10.37%
Revenue Q/Q Growth	-2.35%	6.62%	5.54%	1.93%	2.01%	-3.50%	0.45%	30.87%	-2.68%	-17.29%	3.97%
EBITDA Q/Q Growth	46.72%	-7.05%	10.65%	-1.76%	-4.03%	-3.98%	-12.45%	46.09%	-65.55%	50.43%	-52.55%
EBIT Q/Q Growth	79.10%	-8.10%	14.19%	-1.87%	-6.28%	-6.90%	-26.50%	52.89%	-79.69%	38.68%	-8,257.79%
NOPAT Q/Q Growth	108.47%	-19.68%	-95.15%	73.98%	37.74%	-2.50%	-33.29%	69.97%	-111.65%	32.47%	-152.65%
Net Income Q/Q Growth	120.47%	168.87%	-89.15%	91.48%	-6.18%	-0.90%	-31.44%	69.20%	-51.38%	37.74%	-2,247.68%
EPS Q/Q Growth	147.93%	194.30%	-93.67%	100.00%	-7.04%	-1.68%	-43.92%	73.29%	-52.66%	33.05%	-262.26%
Operating Cash Flow Q/Q Growth	-4.79%	47.69%	-14.67%	-9.89%	39.72%	-4.37%	-58.41%	135.75%	-44.22%	16.40%	41.91%
Free Cash Flow Firm Q/Q Growth	62.40%	-83.47%	29.24%	-99.91%	-125.68%	75.82%	-240.15%	1,445.26%	-91.90%	48.17%	1,354.84%
Invested Capital Q/Q Growth	-41.47%	0.40%	-10.40%	4.06%	17.46%	1.12%	36.18%	12.31%	5.51%	1.69%	-7.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.44%	36.24%	36.01%	36.07%	35.04%	31.80%	29.99%	42.00%	12.33%	1.16%	13.00%
EBITDA Margin	23.08%	30.13%	24.71%	31.05%	23.24%	21.69%	13.49%	38.92%	8.98%	-18.77%	6.11%
Operating Margin	12.21%	17.88%	18.61%	20.77%	18.56%	16.17%	23.99%	33.74%	2.62%	-33.04%	-7.14%
EBIT Margin	13.88%	21.68%	18.30%	25.10%	17.29%	14.27%	5.86%	34.81%	4.51%	-29.72%	-6.70%
Profit (Net Income) Margin	12.74%	25.43%	3.24%	21.90%	16.84%	14.27%	6.01%	38.46%	17.37%	-21.12%	-9.05%
Tax Burden Percent	115.87%	132.12%	22.26%	93.01%	107.36%	119.57%	149.64%	115.69%	677.05%	64.38%	84.27%
Interest Burden Percent	79.19%	88.77%	79.48%	93.81%	90.70%	83.63%	68.49%	95.50%	56.85%	110.36%	160.29%
Effective Tax Rate	3.58%	18.68%	96.65%	18.22%	15.66%	14.57%	22.04%	16.05%	174.39%	0.00%	0.00%
Return on Invested Capital (ROIC)	12.01%	10.52%	0.51%	13.89%	10.80%	6.82%	8.04%	23.55%	-1.83%	-10.77%	-2.36%
ROIC Less NNEP Spread (ROIC-NNEP)	20.38%	1,039.88%	-53.17%	62.57%	14.13%	7.53%	-21.89%	144.42%	142.91%	-4.06%	-25.98%
Return on Net Nonoperating Assets (RNNOA)	2.72%	8.02%	2.05%	5.62%	4.59%	3.61%	-4.88%	12.66%	20.55%	-0.66%	-2.29%
Return on Equity (ROE)	14.73%	18.54%	2.56%	19.51%	15.39%	10.43%	3.16%	36.21%	18.71%	-11.43%	-4.66%
Cash Return on Invested Capital (CROIC)	-60.94%	14.93%	-5.48%	0.01%	-19.46%	-4.05%	-19.42%	23.55%	-29.40%	-9.46%	8.58%
Operating Return on Assets (OROA)	5.30%	6.54%	7.07%	11.05%	7.12%	4.40%	1.51%	19.28%	2.57%	-9.16%	-2.09%
Return on Assets (ROA)	4.86%	7.67%	1.25%	9.64%	6.93%	4.40%	1.54%	21.30%	9.91%	-6.51%	-2.82%
Return on Common Equity (ROCE)	13.90%	17.80%	2.47%	18.69%	14.74%	9.99%	3.06%	35.21%	18.23%	-9.86%	-3.50%
Return on Equity Simple (ROE_SIMPLE)	11.06%	17.94%	2.71%	20.62%	15.37%	10.46%	2.50%	35.27%	17.75%	-11.40%	0.00%
Net Operating Profit after Tax (NOPAT)	333	389	19	573	562	432	622	2,074	-187	-1,244	-257
NOPAT Margin	11.77%	14.54%	0.62%	16.99%	15.65%	13.81%	18.70%	28.33%	-1.95%	-23.13%	-5.00%
Net Nonoperating Expense Percent (NNEP)	-8.38%	-1,029.36%	53.68%	-48.69%	-3.33%	-0.71%	29.93%	-120.87%	-144.74%	-6.71%	23.62%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	18.18%	-1.35%	-9.07%	-1.98%
Cost of Revenue to Revenue	69.56%	63.76%	63.99%	63.93%	64.96%	68.20%	70.01%	58.00%	87.67%	98.84%	87.00%
SG&A Expenses to Revenue	10.63%	13.21%	14.66%	13.22%	14.86%	13.74%	13.27%	7.16%	9.46%	11.49%	10.70%
R&D to Revenue	3.16%	3.01%	2.75%	2.08%	1.62%	1.89%	1.62%	0.98%	0.89%	1.61%	1.00%
Operating Expenses to Revenue	18.23%	18.36%	17.40%	15.29%	16.48%	15.63%	6.00%	8.14%	10.45%	34.20%	20.14%
Earnings before Interest and Taxes (EBIT)	392	580	562	847	621	447	195	2,548	434	-1,598	-344
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	652	807	759	1,048	834	679	449	2,849	864	-1,010	314
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.73	2.33	3.55	2.13	1.88	3.57	3.35	3.11	1.77	1.31	2.28
Price to Tangible Book Value (P/TBV)	4.00	4.65	7.93	4.69	3.70	6.76	4.40	4.08	2.22	1.71	2.98
Price to Revenue (P/Rev)	2.00	3.30	4.24	2.27	2.06	4.87	8.04	3.39	1.74	1.88	3.24
Price to Earnings (P/E)	16.84	13.72	237.54	11.03	13.86	40.55	216.29	9.22	10.61	0.00	0.00
Dividend Yield	2.31%	1.55%	1.09%	1.86%	2.11%	1.08%	0.68%	0.75%	1.12%	1.87%	1.15%
Earnings Yield	5.94%	7.29%	0.42%	9.06%	7.22%	2.47%	0.46%	10.85%	9.42%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.37	2.38	3.47	1.91	1.57	2.64	3.13	2.91	1.62	1.20	1.93
Enterprise Value to Revenue (EV/Rev)	3.17	3.22	4.34	2.50	2.62	5.63	8.27	3.49	1.96	2.57	3.85
Enterprise Value to EBITDA (EV/EBITDA)	13.72	10.69	17.57	8.06	11.28	25.95	61.29	8.98	21.83	0.00	63.02
Enterprise Value to EBIT (EV/EBIT)	22.82	14.85	23.73	9.97	15.16	39.42	141.08	10.04	43.45	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	26.91	22.14	695.88	14.73	16.75	40.75	44.22	12.33	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	24.82	11.72	43.88	15.47	13.08	22.04	79.95	13.41	14.23	19.65	15.45
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.60	0.00	24,163.36	0.00	0.00	0.00	12.33	0.00	0.00	21.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.12	0.60	0.48	0.45	0.75	0.80	0.39	0.39	0.43	0.34	0.33
Long-Term Debt to Equity	0.92	0.54	0.37	0.37	0.70	0.62	0.39	0.39	0.37	0.31	0.32
Financial Leverage	0.13	0.01	-0.04	0.09	0.33	0.48	0.22	0.09	0.14	0.16	0.09
Leverage Ratio	3.03	2.42	2.05	2.02	2.22	2.37	2.05	1.89	1.89	1.76	1.65
Compound Leverage Factor	2.40	2.15	1.63	1.90	2.01	1.98	1.40	1.80	1.07	1.94	2.65
Debt to Total Capital	52.88%	37.54%	32.49%	31.21%	42.70%	44.43%	28.20%	28.20%	30.12%	25.64%	24.61%
Short-Term Debt to Total Capital	9.35%	3.92%	7.46%	5.62%	2.62%	10.01%	0.02%	0.02%	4.52%	2.90%	0.57%
Long-Term Debt to Total Capital	43.53%	33.61%	25.03%	25.58%	40.08%	34.42%	28.18%	28.18%	25.60%	22.73%	24.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.30%	17.23%
Noncontrolling Interests to Total Capital	2.04%	2.34%	2.53%	3.18%	2.26%	2.49%	1.83%	1.83%	1.83%	1.74%	1.91%
Common Equity to Total Capital	45.08%	60.13%	64.98%	65.61%	55.04%	53.08%	69.97%	69.97%	68.05%	56.33%	56.25%
Debt to EBITDA	5.85	2.94	2.42	1.63	3.66	5.26	7.16	1.13	4.82	-3.48	10.16
Net Debt to EBITDA	4.86	-0.44	0.22	0.59	2.23	3.20	1.26	0.20	2.21	-1.19	2.15
Long-Term Debt to EBITDA	4.82	2.63	1.86	1.33	3.43	4.08	7.16	1.13	4.10	-3.09	9.93
Debt to NOPAT	11.47	6.09	95.86	2.97	5.43	8.27	5.17	1.55	-22.24	-2.83	-12.43
Net Debt to NOPAT	9.52	-0.92	8.66	1.08	3.31	5.02	0.91	0.27	-10.18	-0.97	-2.63
Long-Term Debt to NOPAT	9.44	5.45	73.84	2.44	5.10	6.40	5.16	1.55	-18.90	-2.51	-12.14
Altman Z-Score	1.24	2.50	3.19	2.62	1.86	2.44	3.16	3.76	2.41	1.55	2.32
Noncontrolling Interest Sharing Ratio	5.65%	4.01%	3.75%	4.18%	4.27%	4.22%	3.23%	2.78%	2.58%	13.72%	24.81%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.13	2.90	2.06	1.69	1.58	1.22	1.89	1.89	1.47	1.95	2.23
Quick Ratio	0.42	2.45	1.42	1.03	0.92	0.74	1.05	1.05	0.73	1.10	1.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,689	552	-205	0.35	-1,012	-257	-1,503	2,074	-3,002	-1,092	933
Operating Cash Flow to CapEx	158.49%	374.02%	95.68%	78.02%	85.49%	93.94%	36.10%	151.22%	61.66%	42.38%	230.21%
Free Cash Flow to Firm to Interest Expense	-20.68	8.48	-1.77	0.01	-17.55	-3.51	-24.45	16.86	-25.86	-6.59	4.49
Operating Cash Flow to Interest Expense	4.42	11.28	2.64	10.42	12.47	10.93	5.60	15.51	11.42	4.24	6.18
Operating Cash Flow Less CapEx to Interest Expense	1.63	8.27	-0.12	-2.94	-2.12	-0.71	-9.91	5.25	-7.10	-5.76	3.49
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.30	0.39	0.44	0.41	0.31	0.26	0.55	0.57	0.31	0.31
Accounts Receivable Turnover	6.23	5.35	5.58	5.49	5.37	4.92	3.38	7.32	6.21	3.98	6.13
Inventory Turnover	4.93	3.84	3.77	3.34	3.17	2.81	1.65	2.95	3.98	2.90	3.34
Fixed Asset Turnover	1.59	1.14	1.27	1.22	0.91	0.61	0.54	1.14	1.17	0.57	0.57
Accounts Payable Turnover	8.34	6.55	5.61	4.59	4.25	4.04	1.84	3.14	4.07	3.51	4.82
Days Sales Outstanding (DSO)	58.60	68.23	65.37	66.51	68.03	74.25	108.01	49.86	58.81	91.73	59.59
Days Inventory Outstanding (DIO)	74.06	95.13	96.84	109.39	115.02	129.92	221.37	123.57	91.72	125.80	109.39
Days Payable Outstanding (DPO)	43.74	55.75	65.03	79.60	85.84	90.42	198.58	116.06	89.61	104.11	75.77
Cash Conversion Cycle (CCC)	88.91	107.61	97.18	96.31	97.21	113.75	130.81	57.37	60.91	113.42	93.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,782	3,619	3,842	4,415	5,990	6,679	8,804	8,804	11,619	11,467	10,278
Invested Capital Turnover	1.02	0.72	0.82	0.82	0.69	0.49	0.43	0.83	0.94	0.47	0.47
Increase / (Decrease) in Invested Capital	2,021	-163	224	573	1,574	689	2,126	0.00	2,814	-152	-1,190
Enterprise Value (EV)	8,954	8,619	13,338	8,448	9,408	17,607	27,525	25,577	18,856	13,797	19,805
Market Capitalization	5,639	8,829	13,029	7,653	7,390	15,238	26,749	24,802	16,696	10,118	16,647
Book Value per Share	$29.00	$33.74	$33.26	$33.76	$37.09	$40.09	$68.24	$68.14	$80.20	$65.73	$62.01
Tangible Book Value per Share	$12.57	$16.90	$14.87	$15.37	$18.85	$21.17	$51.95	$51.87	$64.09	$50.31	$47.45
Total Capital	7,218	6,312	5,655	5,464	7,144	8,041	11,408	11,408	13,832	13,716	12,975
Total Debt	3,817	2,369	1,837	1,705	3,050	3,572	3,217	3,217	4,167	3,516	3,194
Total Long-Term Debt	3,142	2,122	1,415	1,398	2,863	2,767	3,215	3,215	3,541	3,118	3,119
Net Debt	3,168	-358	166	621	1,857	2,169	567	567	1,907	1,206	675
Capital Expenditures (CapEx)	228	197	318	700	841	850	954	1,262	2,149	1,657	557
Debt-free, Cash-free Net Working Capital (DFCFNWC)	676	144	561	567	390	462	949	949	1,392	1,082	666
Debt-free Net Working Capital (DFNWC)	889	2,414	1,699	1,123	1,003	1,209	2,448	2,448	2,282	2,274	2,284
Net Working Capital (NWC)	214	2,167	1,277	815	816	404	2,446	2,446	1,656	1,876	2,210
Net Nonoperating Expense (NNE)	-27	-292	-80	-166	-43	-15	423	-742	-1,858	-108	208
Net Nonoperating Obligations (NNO)	381	-324	25	656	1,896	2,210	614	614	1,954	1,267	496
Total Depreciation and Amortization (D&A)	260	226	197	201	213	232	254	301	430	589	659
Debt-free, Cash-free Net Working Capital to Revenue	23.90%	5.39%	18.27%	16.81%	10.87%	14.77%	28.51%	12.96%	14.48%	20.11%	12.95%
Debt-free Net Working Capital to Revenue	31.46%	90.17%	55.30%	33.26%	27.96%	38.64%	73.56%	33.44%	23.73%	42.28%	44.42%
Net Working Capital to Revenue	7.58%	80.92%	41.56%	24.16%	22.74%	12.92%	73.50%	33.41%	17.22%	34.88%	42.98%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.01	$0.00	$0.49	$6.40	$5.03	$3.53	$0.00	$0.00	$13.41	($11.20)	($5.76)
Adjusted Weighted Average Basic Shares Outstanding	111.18M	0.00	110.91M	108.43M	105.95M	106.40M	0.00	0.00	117.32M	117.52M	117.66M
Adjusted Diluted Earnings per Share	$3.00	$0.00	$0.49	$6.34	$5.02	$3.52	$0.00	$0.00	$13.36	($11.20)	($5.76)
Adjusted Weighted Average Diluted Shares Outstanding	111.56M	0.00	112.38M	109.46M	106.32M	106.81M	0.00	0.00	117.77M	117.52M	117.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	112.25M	0.00	110.64M	105.75M	106.21M	116.63M	0.00	0.00	117.40M	117.57M	117.85M
Normalized Net Operating Profit after Tax (NOPAT)	454	436	400	573	562	432	622	2,074	183	-450	47
Normalized NOPAT Margin	16.05%	16.28%	13.03%	16.99%	15.65%	13.81%	18.70%	28.33%	1.90%	-8.36%	0.92%
Pre Tax Income Margin	10.99%	19.25%	14.54%	23.55%	15.68%	11.94%	4.02%	33.24%	2.57%	-32.80%	-10.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.81	8.91	4.87	16.16	10.76	6.11	3.17	20.72	3.74	-9.65	-1.66
NOPAT to Interest Expense	4.08	5.97	0.17	10.94	9.74	5.91	10.13	16.86	-1.61	-7.51	-1.24
EBIT Less CapEx to Interest Expense	2.02	5.89	2.12	2.81	-3.83	-5.52	-12.34	10.46	-14.78	-19.65	-4.34
NOPAT Less CapEx to Interest Expense	1.29	2.95	-2.59	-2.42	-4.85	-5.72	-5.39	6.60	-20.13	-17.51	-3.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.60%	25.15%	178.26%	21.56%	38.95%	43.41%	137.03%	8.12%	17.53%	-30.69%	-80.71%
Augmented Payout Ratio	40.93%	25.15%	429.60%	89.21%	38.95%	43.41%	137.03%	8.12%	17.53%	-30.69%	-80.71%

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	117,847,220.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	117,847,220.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2.35
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.46%	-10.10%	-47.26%	-39.65%	-41.37%	-47.72%	-20.86%	-7.02%	-3.46%	15.94%	32.67%
EBITDA Growth	-102.39%	-169.61%	-100.46%	-211.72%	-4,037.27%	142.39%	3,375.79%	165.39%	97.55%	-122.32%	82.57%
EBIT Growth	-114.33%	-192.79%	-110.94%	-336.63%	-777.95%	114.89%	123.16%	108.93%	83.36%	-287.12%	540.76%
NOPAT Growth	-114.22%	-174.22%	-114.99%	-430.75%	-691.94%	100.64%	111.01%	109.65%	80.43%	-4,111.75%	1,445.22%
Net Income Growth	-65.56%	-151.93%	-98.70%	-126.11%	-430.73%	114.11%	196.14%	119.93%	86.05%	-572.04%	567.32%
EPS Growth	-66.23%	-154.47%	-100.76%	-135.51%	-467.70%	105.53%	100.00%	91.84%	81.80%	-1,437.93%	0.00%
Operating Cash Flow Growth	-29.76%	-110.31%	-86.41%	392.34%	-61.75%	100.69%	456.77%	-101.96%	56.58%	8,971.55%	-36.73%
Free Cash Flow Firm Growth	-377.42%	-525.32%	-38.42%	15.45%	68.16%	104.56%	134.98%	131.27%	101.34%	567.61%	77.19%
Invested Capital Growth	40.47%	31.97%	23.60%	15.79%	2.41%	-1.30%	-6.93%	-4.88%	-1.47%	-10.37%	-11.51%
Revenue Q/Q Growth	-2.51%	1.97%	-42.25%	5.12%	-5.29%	-9.08%	-12.57%	23.50%	-1.67%	9.19%	0.05%
EBITDA Q/Q Growth	-108.15%	-2,770.11%	99.21%	-5,377.72%	-201.74%	129.41%	-32.60%	9.35%	-111.30%	-167.90%	651.31%
EBIT Q/Q Growth	-166.42%	-532.90%	85.38%	-254.11%	-146.45%	110.74%	-75.29%	36.51%	-559.35%	-20.74%	184.63%
NOPAT Q/Q Growth	-194.01%	-506.99%	78.88%	-174.43%	-125.09%	100.49%	264.68%	140.51%	-556.55%	-0.18%	240.46%
Net Income Q/Q Growth	-52.59%	-288.12%	102.76%	-1,160.82%	-500.61%	108.02%	-42.08%	-28.61%	-520.37%	-171.57%	181.88%
EPS Q/Q Growth	-53.44%	-303.89%	98.47%	-2,350.00%	-382.14%	103.07%	-100.00%	0.00%	-975.00%	-125.58%	160.31%
Operating Cash Flow Q/Q Growth	753.18%	-115.62%	199.73%	270.47%	-33.71%	-99.72%	80,817.36%	-101.32%	5,036.86%	9.25%	-10.87%
Free Cash Flow Firm Q/Q Growth	-38.86%	-4.25%	28.72%	18.05%	47.71%	114.92%	447.05%	-26.74%	-97.76%	7,349.99%	45.20%
Invested Capital Q/Q Growth	5.59%	5.51%	3.86%	0.07%	-6.62%	1.69%	-2.06%	2.27%	-3.27%	-7.50%	-3.29%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	2.38%	-29.88%	2.86%	-0.74%	-7.68%	11.22%	14.51%	14.80%	8.99%	13.86%	35.06%
EBITDA Margin	-1.01%	-28.49%	-0.43%	-22.42%	-71.42%	23.10%	17.81%	15.77%	-1.81%	-4.45%	24.50%
Operating Margin	-6.06%	-36.07%	-13.19%	-34.44%	-81.85%	0.36%	1.84%	3.57%	-16.59%	-15.22%	16.34%
EBIT Margin	-5.58%	-34.61%	-9.52%	-32.09%	-83.49%	9.86%	2.79%	3.08%	-14.39%	-15.91%	13.46%
Profit (Net Income) Margin	13.88%	-25.60%	1.22%	-12.35%	-78.29%	6.91%	4.58%	2.65%	-11.31%	-28.13%	23.03%
Tax Burden Percent	-202.76%	65.51%	-9.93%	35.74%	89.97%	110.93%	-259.93%	-392.30%	61.86%	140.97%	129.42%
Interest Burden Percent	122.77%	112.95%	129.30%	107.67%	104.22%	63.19%	-63.20%	-21.90%	127.08%	125.43%	132.19%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	13.83%	0.00%	0.00%	0.00%	0.00%	8.46%
Return on Invested Capital (ROIC)	-4.45%	-23.78%	-7.10%	-15.98%	-33.43%	0.14%	0.56%	1.06%	-5.13%	-5.04%	7.77%
ROIC Less NNEP Spread (ROIC-NNEP)	44.13%	-24.43%	42.62%	20.07%	-68.22%	5.19%	6.35%	1.30%	-4.65%	-33.35%	37.02%
Return on Net Nonoperating Assets (RNNOA)	4.44%	-3.51%	1.15%	0.87%	-5.40%	0.84%	0.35%	0.09%	-0.36%	-2.94%	1.43%
Return on Equity (ROE)	-0.01%	-27.29%	-5.96%	-15.11%	-38.83%	0.99%	0.91%	1.15%	-5.50%	-7.98%	9.20%
Cash Return on Invested Capital (CROIC)	-16.60%	-29.40%	-27.71%	-24.97%	-18.90%	-9.46%	-2.30%	-1.16%	0.57%	8.58%	11.20%
Operating Return on Assets (OROA)	-3.37%	-19.74%	-4.37%	-12.76%	-29.88%	3.04%	0.79%	0.86%	-4.11%	-4.96%	4.60%
Return on Assets (ROA)	8.39%	-14.60%	0.56%	-4.91%	-28.02%	2.13%	1.29%	0.74%	-3.23%	-8.77%	7.87%
Return on Common Equity (ROCE)	-0.01%	-26.59%	-5.19%	-13.17%	-33.66%	0.85%	0.71%	0.89%	-4.17%	-6.00%	6.95%
Return on Equity Simple (ROE_SIMPLE)	34.71%	0.00%	3.56%	-3.94%	-17.81%	0.00%	-11.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-98	-595	-126	-345	-776	3.79	14	33	-152	-152	214
NOPAT Margin	-4.24%	-25.25%	-9.23%	-24.11%	-57.30%	0.31%	1.28%	2.50%	-11.61%	-10.66%	14.96%
Net Nonoperating Expense Percent (NNEP)	-48.57%	0.65%	-49.72%	-36.04%	34.79%	-5.05%	-5.79%	-0.24%	-0.49%	28.31%	-29.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-4.30%	-	-	-	0.03%	0.10%	0.24%	-1.09%	-1.17%	1.78%
Cost of Revenue to Revenue	97.62%	129.88%	97.14%	100.74%	107.68%	88.78%	85.49%	85.20%	91.01%	86.14%	64.94%
SG&A Expenses to Revenue	7.45%	7.92%	14.32%	11.81%	11.39%	8.11%	11.47%	9.96%	10.60%	10.89%	9.62%
R&D to Revenue	0.91%	0.97%	1.73%	1.45%	1.65%	1.63%	1.31%	0.94%	0.97%	0.85%	0.64%
Operating Expenses to Revenue	8.44%	9.21%	16.05%	33.70%	74.17%	10.86%	12.68%	11.23%	25.58%	29.08%	12.07%
Earnings before Interest and Taxes (EBIT)	-129	-815	-130	-459	-1,131	121	30	41	-188	-227	192
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-23	-671	-5.85	-321	-968	285	192	210	-24	-64	350
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.99	1.77	0.00	1.25	1.39	1.31	1.09	0.92	1.23	2.28	2.78
Price to Tangible Book Value (P/TBV)	2.45	2.22	0.00	1.57	1.82	1.71	1.42	1.21	1.58	2.98	3.57
Price to Revenue (P/Rev)	1.99	1.74	0.00	1.51	1.71	1.88	1.66	1.48	1.93	3.24	3.85
Price to Earnings (P/E)	5.92	10.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.95%	1.12%	1.22%	1.68%	1.69%	1.87%	2.24%	2.59%	2.00%	1.15%	0.90%
Earnings Yield	16.90%	9.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.88	1.62	0.00	1.18	1.27	1.20	1.05	0.94	1.15	1.93	2.36
Enterprise Value to Revenue (EV/Rev)	2.10	1.96	0.00	1.91	2.21	2.57	2.33	2.16	2.59	3.85	4.26
Enterprise Value to EBITDA (EV/EBITDA)	8.27	21.83	0.00	0.00	0.00	0.00	0.00	0.00	19.37	63.02	49.56
Enterprise Value to EBIT (EV/EBIT)	9.71	43.45	0.00	0.00	0.00	0.00	0.00	0.00	3,038.93	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	12.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.73	14.23	0.00	14.38	23.78	19.65	10.30	13.92	14.20	15.45	21.66
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	200.13	21.23	19.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.36	0.43	0.30	0.31	0.34	0.34	0.34	0.35	0.35	0.33	0.19
Long-Term Debt to Equity	0.34	0.37	0.30	0.31	0.34	0.31	0.30	0.30	0.31	0.32	0.18
Financial Leverage	0.10	0.14	0.03	0.04	0.08	0.16	0.06	0.07	0.08	0.09	0.04
Leverage Ratio	1.91	1.89	1.72	1.74	1.76	1.76	1.63	1.62	1.67	1.65	1.58
Compound Leverage Factor	2.34	2.13	2.23	1.87	1.83	1.11	-1.03	-0.36	2.12	2.07	2.08
Debt to Total Capital	26.47%	30.12%	23.00%	23.48%	25.38%	25.64%	25.62%	25.66%	26.10%	24.61%	15.70%
Short-Term Debt to Total Capital	1.17%	4.52%	0.03%	0.02%	0.02%	2.90%	2.97%	3.15%	3.21%	0.57%	0.62%
Long-Term Debt to Total Capital	25.30%	25.60%	22.97%	23.45%	25.36%	22.73%	22.65%	22.50%	22.89%	24.04%	15.07%
Preferred Equity to Total Capital	0.00%	0.00%	14.59%	14.89%	15.90%	16.30%	16.18%	15.83%	16.09%	17.23%	18.64%
Noncontrolling Interests to Total Capital	1.91%	1.83%	1.74%	1.74%	1.78%	1.74%	1.78%	1.83%	1.96%	1.91%	2.15%
Common Equity to Total Capital	71.62%	68.05%	60.67%	59.89%	56.94%	56.33%	56.42%	56.69%	55.85%	56.25%	63.51%
Debt to EBITDA	1.46	4.82	-7.27	-3.23	-1.75	-3.48	-4.36	-12.87	5.48	10.16	3.98
Net Debt to EBITDA	0.32	2.21	-0.43	-0.49	-0.36	-1.19	-1.10	-3.29	1.18	2.15	-0.49
Long-Term Debt to EBITDA	1.39	4.10	-7.26	-3.22	-1.75	-3.09	-3.85	-11.29	4.80	9.93	3.82
Debt to NOPAT	2.27	-22.24	-4.89	-3.03	-1.94	-2.83	-3.21	-4.99	-35.66	-12.43	-17.53
Net Debt to NOPAT	0.50	-10.18	-0.29	-0.46	-0.39	-0.97	-0.81	-1.28	-7.67	-2.63	2.15
Long-Term Debt to NOPAT	2.17	-18.90	-4.88	-3.03	-1.94	-2.51	-2.83	-4.38	-31.28	-12.14	-16.84
Altman Z-Score	2.62	2.19	0.00	2.02	1.75	1.89	1.66	1.56	1.68	2.34	3.51
Noncontrolling Interest Sharing Ratio	2.90%	2.58%	12.93%	12.83%	13.31%	13.72%	22.58%	22.70%	24.05%	24.81%	24.40%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.81	1.47	2.84	2.67	2.44	1.95	2.11	2.31	2.27	2.23	2.07
Quick Ratio	0.84	0.73	1.64	1.55	1.40	1.10	1.20	1.38	1.38	1.29	1.11
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3,270	-3,409	-2,430	-1,991	-1,041	155	850	623	14	1,037	1,506
Operating Cash Flow to CapEx	115.20%	-14.36%	16.91%	81.07%	79.36%	0.19%	298.64%	-6.02%	272.99%	262.09%	350.89%
Free Cash Flow to Firm to Interest Expense	-111.49	-99.15	-64.00	-56.59	-21.80	3.48	17.36	12.47	0.27	17.96	45.48
Operating Cash Flow to Interest Expense	21.44	-2.86	2.58	10.31	5.04	0.02	11.14	-0.14	6.98	6.72	10.45
Operating Cash Flow Less CapEx to Interest Expense	2.83	-22.75	-12.68	-2.41	-1.31	-7.94	7.41	-2.54	4.42	4.16	7.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.57	0.46	0.40	0.36	0.31	0.28	0.28	0.29	0.31	0.34
Accounts Receivable Turnover	6.87	6.21	5.64	5.02	4.77	3.98	4.80	4.81	5.32	6.13	7.49
Inventory Turnover	2.79	3.98	3.32	2.96	2.88	2.90	2.76	2.68	2.72	3.34	2.98
Fixed Asset Turnover	1.34	1.17	0.98	0.84	0.74	0.57	0.53	0.52	0.54	0.57	0.62
Accounts Payable Turnover	3.28	4.07	4.16	3.69	3.80	3.51	4.44	4.22	4.08	4.82	4.84
Days Sales Outstanding (DSO)	53.16	58.81	64.70	72.65	76.52	91.73	75.97	75.93	68.61	59.59	48.74
Days Inventory Outstanding (DIO)	131.01	91.72	109.85	123.32	126.87	125.80	132.26	136.34	134.23	109.39	122.31
Days Payable Outstanding (DPO)	111.19	89.61	87.84	98.85	95.99	104.11	82.21	86.46	89.45	75.77	75.41
Cash Conversion Cycle (CCC)	72.99	60.91	86.71	97.12	107.39	113.42	126.02	125.82	113.40	93.22	95.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,012	11,619	12,068	12,076	11,277	11,467	11,231	11,486	11,111	10,278	9,939
Invested Capital Turnover	1.05	0.94	0.77	0.66	0.58	0.47	0.44	0.42	0.44	0.47	0.52
Increase / (Decrease) in Invested Capital	3,172	2,814	2,304	1,647	265	-152	-836	-590	-166	-1,190	-1,293
Enterprise Value (EV)	20,737	18,856	0.00	14,254	14,342	13,797	11,845	10,793	12,830	19,805	23,419
Market Capitalization	19,670	16,696	0.00	11,226	11,132	10,118	8,468	7,374	9,542	16,647	21,157
Book Value per Share	$84.35	$80.20	$79.16	$76.47	$68.11	$65.73	$66.28	$68.04	$65.95	$62.01	$64.62
Tangible Book Value per Share	$68.44	$64.09	$63.28	$60.78	$52.08	$50.31	$50.67	$51.84	$51.33	$47.45	$50.23
Total Capital	13,821	13,832	15,324	15,006	14,060	13,716	13,813	14,122	13,895	12,975	11,990
Total Debt	3,658	4,167	3,525	3,523	3,569	3,516	3,539	3,623	3,626	3,194	1,882
Total Long-Term Debt	3,496	3,541	3,519	3,520	3,566	3,118	3,129	3,178	3,181	3,119	1,807
Net Debt	803	1,907	210	532	725	1,206	896	926	781	675	-231
Capital Expenditures (CapEx)	546	684	579	448	303	356	183	120	130	148	99
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,745	1,392	1,721	1,440	1,097	1,082	1,055	1,193	1,065	666	668
Debt-free Net Working Capital (DFNWC)	3,346	2,282	3,777	3,270	2,762	2,274	2,573	3,000	2,996	2,284	1,758
Net Working Capital (NWC)	3,184	1,656	3,772	3,267	2,759	1,876	2,163	2,555	2,551	2,210	1,683
Net Nonoperating Expense (NNE)	-419	8.39	-142	-168	284	-81	-35	-1.92	-3.95	250	-115
Net Nonoperating Obligations (NNO)	849	1,954	268	592	786	1,267	957	987	842	496	-169
Total Depreciation and Amortization (D&A)	105	144	124	138	164	163	162	169	164	164	158
Debt-free, Cash-free Net Working Capital to Revenue	17.65%	14.48%	20.50%	19.31%	16.88%	20.11%	20.71%	23.90%	21.52%	12.95%	12.16%
Debt-free Net Working Capital to Revenue	33.86%	23.73%	44.98%	43.85%	42.48%	42.28%	50.52%	60.09%	60.58%	44.42%	31.99%
Net Working Capital to Revenue	32.22%	17.22%	44.92%	43.81%	42.43%	34.88%	42.46%	51.18%	51.57%	42.98%	30.63%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.58	($5.28)	($0.08)	($1.96)	($9.45)	$0.29	$0.00	($0.16)	($1.72)	($3.88)	$2.35
Adjusted Weighted Average Basic Shares Outstanding	117.35M	117.32M	117.45M	117.53M	117.54M	117.52M	117.60M	117.67M	117.69M	117.66M	117.85M
Adjusted Diluted Earnings per Share	$2.57	($5.24)	($0.08)	($1.96)	($9.45)	$0.29	$0.00	($0.16)	($1.72)	($3.88)	$2.34
Adjusted Weighted Average Diluted Shares Outstanding	117.78M	117.77M	117.45M	117.53M	117.54M	117.52M	117.60M	117.67M	117.69M	117.66M	118.61M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.35M	117.40M	117.53M	117.53M	117.54M	117.57M	117.66M	117.68M	117.70M	117.85M	117.93M
Normalized Net Operating Profit after Tax (NOPAT)	-97	-595	-126	-345	-196	3.79	13	36	-24	-151	237
Normalized NOPAT Margin	-4.19%	-25.25%	-9.23%	-24.11%	-14.50%	0.31%	1.22%	2.74%	-1.80%	-10.56%	16.62%
Pre Tax Income Margin	-6.85%	-39.09%	-12.32%	-34.55%	-87.02%	6.23%	-1.76%	-0.67%	-18.29%	-19.96%	17.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-4.39	-23.71	-3.41	-13.04	-23.68	2.72	0.61	0.82	-3.69	-3.93	5.81
NOPAT to Interest Expense	-3.34	-17.30	-3.31	-9.80	-16.25	0.08	0.28	0.67	-2.98	-2.63	6.45
EBIT Less CapEx to Interest Expense	-23.00	-43.61	-18.67	-25.76	-30.03	-5.24	-3.12	-1.58	-6.25	-6.50	2.83
NOPAT Less CapEx to Interest Expense	-21.95	-37.20	-18.57	-22.52	-22.60	-7.87	-3.45	-1.73	-5.54	-5.20	3.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	7.74%	17.53%	58.54%	-67.29%	-18.22%	-30.69%	-37.09%	-44.20%	1,733.24%	-80.71%	-212.80%
Augmented Payout Ratio	7.74%	17.53%	58.54%	-67.29%	-18.22%	-30.69%	-37.09%	-44.20%	1,733.24%	-80.71%	-212.80%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Albemarle (ALB) based on the last four years of quarterly results in the data you provided. The focus is on cash flow, profitability, and balance-sheet liquidity, with a view toward how these have evolved over time.

Operating cash flow remained positive across most 2025 quarters (Q1: +$545.4M, Q3: +$355.6M, Q4: +$388.5M), signaling solid cash generation even as reported net income fluctuated. Q2 2025 was a brief exception with a small negative cash flow from continuing operating activities (-$7.2M).
Free cash flow in several 2025 quarters was solid (rough estimates): Q1 around +$362.8M, Q3 around +$223.4M, and Q4 around +$233.1M, reflecting cash availability after capex.
Liquidity remained robust. Cash and equivalents were about $1.93B in Q3 2025, and total current assets (~$4.55B) versus total current liabilities (~$2.0B) produced a current ratio of roughly 2.3x, indicating ample short-term liquidity.
The company continued to pay a regular dividend of $0.405 per share per quarter (cash dividends per share), providing a steady income stream for shareholders.
Impairment charges occurred in 2025 (notably a one-time impairment of about $181.1M in Q3 2025), which reduced operating income but are non-cash/non-recurring in nature. This is a notable one-off headwind rather than a persistent operational issue.
Capital expenditures remained steady, with quarterly purchases of property, plant & equipment typically in the low-to-mid hundreds of millions (roughly $120–$180M per quarter), indicating ongoing investment in the asset base without an outsized capex spike.
Top-line revenue declined in 2025, with Q4 2025 operating revenue of about $1.43B versus about $2.32B in Q4 2024 (roughly a 39% year-over-year drop), signaling meaningful revenue pressure.
Operating income was negative in the latter part of 2025 (Q3 and Q4 2025), with Total Operating Income around -$217M in both Q3 and Q4 2025, indicating profitability headwinds.
Net income attributable to common shareholders was negative in several 2025 quarters (for example, Q4 2025 around -$455.9M; Q3 2025 around -$202.4M), underscoring ongoing GAAP losses despite cash-generation strength.
Financing cash flow remained negative through 2025 as debt repayments and dividends outpaced new financing, contributing to net cash outflows from financing activities (e.g., Q4 2025 around -$533.0M).

05/21/26 12:29 PM ETAI Generated. May Contain Errors.

Albemarle Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Albemarle's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Albemarle's net income appears to be on a downward trend, with a most recent value of -$465.21 million in 2025, falling from $360.06 million in 2015. The previous period was -$1.14 billion in 2024. See Albemarle's forecast for analyst expectations on what's next for the company.

Albemarle's total operating income in 2025 was -$367.08 million, based on the following breakdown:

Total Gross Profit: $668.72 million
Total Operating Expenses: $1.04 billion

Over the last 10 years, Albemarle's total revenue changed from $2.83 billion in 2015 to $5.14 billion in 2025, a change of 82.0%.

Albemarle's total liabilities were at $6.59 billion at the end of 2025, a 2.9% increase from 2024, and a 6.4% increase since 2015.

In the past 10 years, Albemarle's cash and equivalents has ranged from $213.73 million in 2015 to $2.27 billion in 2016, and is currently $1.62 billion as of their latest financial filing in 2025.

Over the last 10 years, Albemarle's book value per share changed from 29.00 in 2015 to 62.01 in 2025, a change of 113.8%.

Related Companies

Financial statements for NYSE:ALB last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Albemarle (ALB) Financials

Financials Breakdown Chart

Key Financial Trends

Albemarle Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Albemarle (ALB) Financials

Annual Income Statements for Albemarle

Quarterly Income Statements for Albemarle

Annual Cash Flow Statements for Albemarle

Quarterly Cash Flow Statements for Albemarle

Annual Balance Sheets for Albemarle

Quarterly Balance Sheets for Albemarle

Annual Metrics And Ratios for Albemarle

Quarterly Metrics And Ratios for Albemarle

Financials Breakdown Chart

Key Financial Trends

Albemarle Financials - Frequently Asked Questions

When does Albemarle's fiscal year end?

How has Albemarle's net income changed over the last 10 years?

What is Albemarle's operating income?

How has Albemarle's revenue changed over the last 10 years?

How much debt does Albemarle have?

How much cash does Albemarle have?

How has Albemarle's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools